"Epic Clinical Research is a dedicated research site of multi-specialty physicians, conducting Phase I-IV research studies. We are pleased to offer a highly professional research team with a proven track record in clinical trials. Our mission is to satisfy all Sponsor and CRO objectives, from delivering the highest quality data to meeting and even exceeding enrollment goals in a timely fashion. The key to our success can be found in our highly-educated and diverse corporate team, which remains intensely involved in all aspects of our clinical operations."

During the past decade, Epic Clinical Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Epic Clinical Research" #1 sponsor was "Eli Lilly and Company" with 1 trials, followed by "Innovent Biologics (Suzhou) Co. Ltd." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Pardes Biosciences, Inc." with 1 trials sponsored and "Satsuma Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Epic Clinical Research" are "COVID-19" (2 trials), "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials), "Migraine" (1 trials), "Migraine With Aura" (1 trials) and "Migraine Without Aura" (1 trials). Many other conditions were trialed in "Epic Clinical Research" in a lesser frequency.

Most popular intervention types in "Epic Clinical Research" are "Drug" (3 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Dihydroergotamine" (1 trials), "ExPEC9V" (1 trials), "IBI314" (1 trials) and "PBI-0451 (Pomotrelvir)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Epic Clinical Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Epic Clinical Research". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Epic Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Epic Clinical Research, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".